{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:37:59Z","timestamp":1742387879703},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T00:00:00Z","timestamp":1441670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Murdoch Childrens Research Institute"},{"name":"Neurofibromatosis Research Program","award":["NF140051; NF140033"],"award-info":[{"award-number":["NF140051; NF140033"]}]}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ebiom.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,9,12]],"date-time":"2015-09-12T00:03:46Z","timestamp":1442016226000},"page":"1290-1291","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bridging the Gap Between Mouse Behavior and Human Cognition in Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"2","author":[{"given":"Jonathan M.","family":"Payne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2015.09.013_bb0005","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dmcn.12361","article-title":"Relationship between cognitive dysfunction, gait and motor impairment in children and adolescents with neurofibromatosis type 1","volume":"56","author":"Champion","year":"2014","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ebiom.2015.09.013_bb0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/brain\/awp299","article-title":"Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome","volume":"133","author":"Heise","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2015.09.013_bb0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181a609c5","article-title":"Deficient intracortical inhibition (SICI) during movement preparation after chronic stroke","volume":"72","author":"Hummel","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2015.09.013_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.300.3.287","article-title":"Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial","volume":"300","author":"Krab","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2015.09.013_bb0025","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ebiom.2015.09.013_bb0030","series-title":"Neurofibromatosis Type 1: Symptoms, Treatment and Prognosis","article-title":"Cognition and behaviour in neurofibromatosis type 1: pathogenesis and emerging therapies","author":"Payne","year":"2013"},{"key":"10.1016\/j.ebiom.2015.09.013_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","article-title":"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1","volume":"64","author":"Ribeiro","year":"2015","journal-title":"Cortex"},{"key":"10.1016\/j.ebiom.2015.09.013_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-neuro-060909-153215","article-title":"Molecular and cellular mechanisms of learning disabilities: a focus on NF1","volume":"33","author":"Shilyansky","year":"2010","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ebiom.2015.09.013_bb0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1474-4422(13)70227-8","article-title":"Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial","volume":"12","author":"van der Vaart","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ebiom.2015.09.013_bb0050","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ebiom.2015.08.036","article-title":"Impairment of procedural learning and motor intracortical inhibition in neurofibromatosis type 1 patients","volume":"2","author":"Zimerman","year":"2015","journal-title":"EBioMedicine"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239641530133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239641530133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:57:22Z","timestamp":1537365442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239641530133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S235239641530133X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.09.013","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the Gap Between Mouse Behavior and Human Cognition in Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.08.036","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}